
Sign up to save your podcasts
Or


Ian Pavord (Thorax editor) talks to Peter Gibson (professor of respiratory medicine, John Hunter Hospital, New South Wales, Australia) about non-eosinophilic asthma, particularly neutrophilic asthma.
They discuss the stability of the different inflammatory phenotypes, tools to recognise non-eosinophilic asthma, whether these patients benefit from inhaled steroids, and Professor Gibson’s paper investigating the relationship between H influenzae respiratory infection and neutrophilic asthma.
See also:
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma
By BMJ Group4
11 ratings
Ian Pavord (Thorax editor) talks to Peter Gibson (professor of respiratory medicine, John Hunter Hospital, New South Wales, Australia) about non-eosinophilic asthma, particularly neutrophilic asthma.
They discuss the stability of the different inflammatory phenotypes, tools to recognise non-eosinophilic asthma, whether these patients benefit from inhaled steroids, and Professor Gibson’s paper investigating the relationship between H influenzae respiratory infection and neutrophilic asthma.
See also:
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma

137 Listeners

498 Listeners

37 Listeners

51 Listeners

63 Listeners

5 Listeners

8 Listeners

5 Listeners

3 Listeners

3 Listeners

37 Listeners

5 Listeners

8 Listeners

38 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

36 Listeners

14 Listeners

3 Listeners

3 Listeners

27 Listeners

1,151 Listeners

191 Listeners

513 Listeners

24 Listeners

9 Listeners

372 Listeners

56 Listeners

233 Listeners